1 / 15

The global meperidine | Coherent Market Insights

North America is expected to witness significant growth during the forecast period owing to the increasing prevalence of pain causing conditions in the region.<br><br><br>

shrutiCMI
Download Presentation

The global meperidine | Coherent Market Insights

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Coherent Market Insights Market Research and Business Consulting Services https://www.coherentmarketinsights.com/ COVID-19 Impact Tracker

  2. MEPERIDINE (DEMEROL) MARKET ANALYSIS Meperidine (Demerol) Market,by Dosage Form (Tablets, Injection,and Syrup), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027.

  3. The global meperidine (Demerol) market is estimated to be valued at US$ 2,089.1 Mn in 2020 and is expected to increase to US$ 2,784.3 Mn by 2027,witnessing a CAGR of 4.2% during the forecast period (2020-2027). Drivers • Opioids such as meperidine are used as pre-anesthetic medication in the surgical procedure, and are also used as part of anesthesia to prevent pain after surgical procedure. Opioids are also used in surgical treatment related to cancer. They are also used in cardiovascular procedures to obtain the relief from post-surgical treatment pain. The increasing number of surgeries worldwide is expected to support growth of the market during the forecast period.

  4. For instance, according to Eurostat, 2019, there were at least 1.4 million caesarean sections performed in the EU in 2017. Moreover, pain management related to cancer disease, back pain, neuropathic pain, migraine, osteoarthritis, and pain which occurs after the surgical procedures also involves use of opioids such as meperidine.The rising prevalence of such diseases is expected to support global meperidine (Demerol) market growth during the forecast period.

  5. Figure 1.Global Meperidine (Demerol) Market Share (%), By Value, By Region (2019)

  6. Market Growth • In many disease cases, there is no cure for chronic pain, therefore physicians prefer pharmacological methods to treat the pain and decrease the suffering. The patients suffering from intractable chronic pain, which cannot be managed with conventional treatment methods may require opioid drug therapy, especially for chronic diseases such as cancer. The pain does not stop after the treatment in cancer, and to get relief from this continuous and long lasting pain, patients prefer to use opioid drugs such as meperidine.

  7. Thus, the increasing prevalence of diseases such as cancer is expected to support the global meperidine (Demerol) market growth during the forecast period. According to the World Health Organization’s 2018 report,cancer was the second leading cause of morbidity and mortality worldwide and was responsible for an estimated 9.6 million deaths in 2018. According to the same source,globally,around 1 in 6 deaths occur due to cancer annually.

  8. Regional Analysis • Regional segmentation of the global meperidine (Demerol) market includes North America,Latin America,Europe,Asia Pacific,Middle East, and Africa. • North America is expected to witness significant growth during the forecast period owing to the increasing prevalence of pain causing conditions such as osteoarthritis in the region.For instance,according to the Centers for Disease Control and Prevention’s (CDC) report,osteoarthritis affected more than 30 million U.S adults in 2018 and it has been estimated that 70 million people are likely to suffer from osteoarthritis by 2040. • Asia Pacific is also expected to witness growth in the global meperidine (Demerol) market owing to presence of a vast customer base and a number of generic manufacturers in the region.

  9. Figure 2.Global Meperidine (Demerol) Market Value (US$ Mn) Analysis and Forecast & Y-o-Y Growth (%),(2019-2027)

  10. Market Restraints Factors such as increasing drug/opioid addiction, presence of alternative opioid medications, and side effects such as accumulation of toxic metabolite normeperidine, and possible generalized seizures affecting both cerebral hemispheres and loss of consciousness may restrict the global meperidine (Demerol) market growth during the forecast period.

  11. Competitive Section Key players covered as a part of this market are Pfizer, Inc., Hikma Pharmaceuticals USA Inc.,Epic Pharma, Inc., and Vintage Pharmaceuticals, Inc.

  12. Request Sample Report • Request Customization • Download PDF Brochure • Talk to Analyst Reference: https://www.coherentmarketinsights.com/market-insight/meperidine-market-3816

  13. About Us Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. What we provide: • Customized Market Research Services • Industry Analysis Services • Business Consulting Services • Market Intelligence Services • Long term Engagement Model • Country Specific Analysis

  14. Contact Us Mr. Shah Coherent Market Insights Pvt.Ltd. Address: 1001 4th Ave, #3200 Seattle, WA 98154, U.S. Phone: +1-206-701-6702 Email: sales@coherentmarketinsights.com

  15. Thank You! Kindly follow CMI Social Media Profiles for the latest company updates Facebook Linkedin Twitter https://www.coherentmarketinsights.com/

More Related